Mid Atlantic Financial Management’s Idexx Laboratories IDXX Stock Holding History

Mid Atlantic Financial Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$436K	Sell	701 -112	-14%	-$75.3K	0.03%	508
2021 Q2	$513K	Buy	813 +190	+30%	+$105K	0.03%	456
2021 Q1	$305K	Sell	623 -34	-5%	-$17K	0.02%	621
2020 Q4	$328K	Buy	+657	New	+$294K	0.03%	544

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mid Atlantic Financial Management's IDXX Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Idexx Laboratories (IDXX) stake by 14% in Q3 2021, selling an estimated $75.3K and leaving 701 shares worth $436K. The position accounts for 0.03% of the portfolio, ranked #508.

Mid Atlantic Financial Management first reported a position in IDXX in Q4 2020 and has held it in 4 quarters since. The position peaked at $513K in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

Mid Atlantic Financial Management held 701 shares of Idexx Laboratories worth $436K as of Q3 2021.
Mid Atlantic Financial Management sold 112 Idexx Laboratories shares in Q3 2021, an estimated $75.3K.
Idexx Laboratories made up 0.03% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #508 holding.
Mid Atlantic Financial Management first reported a position in Idexx Laboratories in Q4 2020 and has held it in 4 quarters since.
Mid Atlantic Financial Management's Idexx Laboratories position peaked at $513K in Q2 2021.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.